In the BioHarmony Drug Report Database

"Preview" Icon

Sulindac

Clinoril (sulindac) is a small molecule pharmaceutical. Sulindac was first approved as Clinoril on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, gouty arthritis, inflammation, and osteoarthritis amongst others in the USA. It is known to target prostaglandin G/H synthase 2, retinoic acid receptor RXR-alpha, and prostaglandin G/H synthase 1.

 

Trade Name

 

Clinoril
 

Common Name

 

sulindac
 

ChEMBL ID

 

CHEMBL15770
 

Indication

 

ankylosing spondylitis, bursitis, gouty arthritis, inflammation, osteoarthritis, rheumatoid arthritis, shoulder pain, tendinopathy
 

Drug Class

 

Anti-inflammatory agents (acetic acid derivatives)

Image (chem structure or protein)

Sulindac structure rendering